These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6749759)

  • 1. A decisive period in cefoxitin prophylaxis of experimental synergistic wound infection produced by Bacteroides fragilis and Escherichia coli.
    Shapiro M; Sacks T
    Isr J Med Sci; 1982 Aug; 18(8):863-5. PubMed ID: 6749759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing antibiotic dose decreases polymicrobial infection after hemorrhagic shock.
    Livingston DH; Malangoni MA
    Surg Gynecol Obstet; 1993 May; 176(5):418-22. PubMed ID: 8480263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saline wound irrigation reduces the postoperative infection rate in guinea pigs.
    Badia JM; Torres JM; Tur C; Sitges-Serra A
    J Surg Res; 1996 Jul; 63(2):457-9. PubMed ID: 8661242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of cefoxitin in vitro and in vivo: a study in patients with biliary tract infection undergoing percutaneous transhepatic biliary drainage.
    Masuda G; Tabata I; Isawa T; Yamazaki E; Mizuoka K
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):367-72. PubMed ID: 3526054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
    Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
    Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots.
    Hau T; Jacobs DE; Hawkins NL
    Arch Surg; 1986 Feb; 121(2):163-8. PubMed ID: 3511886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hemothorax on experimental empyema thoracis in the guinea pig.
    Mavroudis C; Ganzel BL; Katzmark S; Polk HC
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):42-9. PubMed ID: 3880847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-chain fatty acids on in vitro bacterial growth of Bacteroides fragilis and Escherichia coli.
    Mortensen FV; Møller JK; Hessov I
    APMIS; 1999 Feb; 107(2):240-4. PubMed ID: 10225323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
    Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous injection of mice with bacteroides fragilis and Escherichia coli: role of Thioglycollate medium in the infectious process.
    Rodloff AC; Rodloff S; Fischer B; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 May; 254(3):405-12. PubMed ID: 6372324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antibiotics for prevention of Bacteroides fragilis wound sepsis in rats.
    Clark DG; Schweizer RT
    Am Surg; 1980 Mar; 46(3):180-3. PubMed ID: 7377663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trends in antimicrobial resistance of Pseudomonas aeruginosa, Escherichia coli and Bacteroides fragilis (1997-2001)].
    García-Rodríguez JA; Casal M; Rodríguez F;
    Rev Esp Quimioter; 2003 Dec; 16(4):421-7. PubMed ID: 14961136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination patterns of Escherichia coli and bacteroides fragilis from the peritoneal cavity. Studies with experimental peritonitis in pigs.
    Nyström PO; Skau T
    Acta Chir Scand; 1983; 149(4):383-8. PubMed ID: 6351520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
    Brook I
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S376-7. PubMed ID: 7548603
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
    Huelves L; Gracia M; Del Prado G; Rodríguez-Cerrato V; Martínez-Marín C; Ponte C; Soriano F; Coronel P; Gimeno M; Blanco J
    Int J Antimicrob Agents; 2006 Aug; 28(2):151-3. PubMed ID: 16815688
    [No Abstract]   [Full Text] [Related]  

  • 18. The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds.
    Kelly MJ
    J Med Microbiol; 1978 Nov; 11(4):513-23. PubMed ID: 364068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ceftizoxime and comparative compounds against Bacteroides fragilis in a mouse model of anaerobic infection.
    Grappel SF; Phillips L; Actor P
    J Antibiot (Tokyo); 1984 Apr; 37(4):384-8. PubMed ID: 6327593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pure or combined inocula of Escherichia coli and Bacteroides fragilis on the liver and related metabolism.
    Rink RD; Kaelin CR; Raque G; Trachtenberg LS; Fry DE
    Lab Invest; 1982 Mar; 46(3):282-7. PubMed ID: 7038296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.